<code id='97315E7FF7'></code><style id='97315E7FF7'></style>
    • <acronym id='97315E7FF7'></acronym>
      <center id='97315E7FF7'><center id='97315E7FF7'><tfoot id='97315E7FF7'></tfoot></center><abbr id='97315E7FF7'><dir id='97315E7FF7'><tfoot id='97315E7FF7'></tfoot><noframes id='97315E7FF7'>

    • <optgroup id='97315E7FF7'><strike id='97315E7FF7'><sup id='97315E7FF7'></sup></strike><code id='97315E7FF7'></code></optgroup>
        1. <b id='97315E7FF7'><label id='97315E7FF7'><select id='97315E7FF7'><dt id='97315E7FF7'><span id='97315E7FF7'></span></dt></select></label></b><u id='97315E7FF7'></u>
          <i id='97315E7FF7'><strike id='97315E7FF7'><tt id='97315E7FF7'><pre id='97315E7FF7'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:31
          Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT
          Adobe

          At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

          But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

          advertisement

          The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          PEPFAR is under serious threat — and so is global health
          PEPFAR is under serious threat — and so is global health

          AhospitalinNairobi,Kenya,thatisabeneficiaryoftheglobalhealthinitiativePEPFAR.BrentStirton/GettyImage

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Hospitals consider fixing cancer drug shortages on their own

          CivicaRxisconsideringamoveintochemotherapiesamiddrugshortages.AdobeWASHINGTON—Anonprofitformedbyhosp